Literature DB >> 24034008

Ex vivo lung perfusion increases the pool of lung grafts: analysis of its potential and real impact on a lung transplant program.

M Boffini1, D Ricci, C Barbero, R Bonato, M Ribezzo, E Mancuso, M Attisani, E Simonato, P Magistroni, M Mansouri, P Solidoro, S Baldi, D Pasero, A Amoroso, M Rinaldi.   

Abstract

BACKGROUND: Among the strategies to increase the number of lung transplants, ex vivo lung perfusion (EVLP) represents a novel technique to expand the donor pool.
METHODS: Data from donors referred to our center were retrospectively analyzed to identify grafts that could potentially be potentially reconditioned by EVLP and for comparison with those obtained by clinical application of EVLP program in our center.
RESULTS: Among 75 rejected lungs, 23 organs have been identified as potentially treatable with EVLP with a hypothetic increase of lung transplant activity of 53%. After the introduction of the EVLP program in our center, lung transplantation with reconditioned grafts was performed in 7 (23%) patients with a 30% increase in transplant procedures.
CONCLUSION: Although less than expected, EVLP increased the number of lungs suitable for transplantation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24034008     DOI: 10.1016/j.transproceed.2013.08.004

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

Review 1.  Ex vivo lung perfusion.

Authors:  Tiago N Machuca; Marcelo Cypel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

2.  Cell replacement in human lung bioengineering.

Authors:  Brandon A Guenthart; John D O'Neill; Jinho Kim; Kenmond Fung; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Heart Lung Transplant       Date:  2018-11-22       Impact factor: 10.247

3.  Extracorporeal membrane oxygenation after lung transplantation: risk factors and outcomes analysis.

Authors:  Massimo Boffini; Erika Simonato; Davide Ricci; Fabrizio Scalini; Matteo Marro; Stefano Pidello; Matteo Attisani; Paolo Solidoro; Paolo Olivo Lausi; Vito Fanelli; Cristina Barbero; Luca Brazzi; Mauro Rinaldi
Journal:  Ann Cardiothorac Surg       Date:  2019-01

Review 4.  Specialized Donor Care Facility Model and Advances in Management of Thoracic Organ Donors.

Authors:  Amit Bery; Gary Marklin; Akinobu Itoh; Daniel Kreisel; Tsuyoshi Takahashi; Bryan F Meyers; Ruben Nava; Benjamin D Kozower; Hailey Shepherd; G Alexander Patterson; Varun Puri
Journal:  Ann Thorac Surg       Date:  2021-01-07       Impact factor: 5.102

5.  Electrical Impedance as a Noninvasive Metric of Quality in Allografts Undergoing Normothermic Ex Vivo Lung Perfusion.

Authors:  Danielle M Peterson; Eliza W Beal; Brenda F Reader; Curtis Dumond; Sylvester M Black; Bryan A Whitson
Journal:  ASAIO J       Date:  2022-01-20       Impact factor: 3.826

6.  The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Lee A Borthwick; Colin Gillespie; Kasim Jiwa; Jonathan Scott; Paul Henderson; Jonny Mayes; Rosalba Romano; Marius Roman; Simi Ali; James E Fildes; Nandor Marczin; John H Dark; Andrew J Fisher
Journal:  J Heart Lung Transplant       Date:  2017-05-12       Impact factor: 10.247

7.  Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Danai M Karamanou; Colin S Gillespie; Faruk Özalp; Tanveer Butt; Paul Hill; Kasim Jiwa; Hannah R Walden; Nicola J Green; Lee A Borthwick; Stephen C Clark; Henning Pauli; Kate F Gould; Paul A Corris; Simi Ali; John H Dark; Andrew J Fisher
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.